Literature DB >> 12574410

D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance.

Jérôme Baufreton1, Maurice Garret, Alicia Rivera, Adélaïda de la Calle, François Gonon, Bernard Dufy, Bernard Bioulac, Anne Taupignon.   

Abstract

Dopamine is a crucial factor in basal ganglia functioning. In current models of basal ganglia, dopamine is postulated to act on striatal neurons. However, it may also act on the subthalamic nucleus (STN), a key nucleus in the basal ganglia circuit. The data presented here were obtained in brain slices using whole-cell patch clamp. They reveal that D5 dopamine receptors strengthen electrical activity in the subset of subthalamic neurons endowed with burst-firing capacity, resulting in longer discharges of spontaneous or evoked bursts. To distinguish between D1 and D5 subtypes, the action of agonists in the D1/D5 receptor family was first investigated on rat subthalamic neurons. Single-cell reverse transcription-PCR profiling showed that burst-competent neurons only expressed D5 receptors. Accordingly, receptors localized in postsynaptic membranes within the STN were labeled by a D5-specific antibody. Second, agonists in the D1/D5 family were tested in mouse brain slices. It was found that these agonists were active in D1 receptor knock-out mice in a similar way to wild-type mice or rats. This proved that D5 rather than D1 receptors were involved. Pharmacological tools (dihydropyridines, omega-conotoxins, and calciseptine) were used to identify the target of D5 receptors as an L-type channel. This was reached via G-protein and protein kinase A. The action of dopamine on D5 receptors therefore shapes neuronal activity. It contributes to normal information processing in basal ganglia outside striatum. This finding may be useful in drug therapy for various disorders involving changes in STN activity, such as Parkinson's disease and related disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574410      PMCID: PMC6741933     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

1.  A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus.

Authors:  D Plenz; S T Kital
Journal:  Nature       Date:  1999-08-12       Impact factor: 49.962

2.  Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors.

Authors:  F Liu; Q Wan; Z B Pristupa; X M Yu; Y T Wang; H B Niznik
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

3.  Relationship of activity in the subthalamic nucleus-globus pallidus network to cortical electroencephalogram.

Authors:  P J Magill; J P Bolam; M D Bevan
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

4.  D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.

Authors:  J Flores-Hernandez; S Hernandez; G L Snyder; Z Yan; A A Fienberg; S J Moss; P Greengard; D J Surmeier
Journal:  J Neurophysiol       Date:  2000-05       Impact factor: 2.714

5.  Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?

Authors:  B P Bejjani; I Arnulf; S Demeret; P Damier; A M Bonnet; J L Houeto; Y Agid
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

6.  Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432.

Authors:  K Chergui; M G Lacey
Journal:  Neuropharmacology       Date:  1999-02       Impact factor: 5.250

7.  Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography.

Authors:  G Flores; J J Liang; A Sierra; D Martínez-Fong; R Quirion; J Aceves; L K Srivastava
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

8.  Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors.

Authors:  I Brünig; M Sommer; H Hatt; J Bormann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

9.  Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.

Authors:  O K Hassani; J Féger
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

10.  Ionic basis for plateau potentials in deep dorsal horn neurons of the rat spinal cord.

Authors:  V Morisset; F Nagy
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

View more
  32 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.

Authors:  Jonathan Chetrit; Anne Taupignon; Lionel Froux; Stephanie Morin; Rabia Bouali-Benazzouz; Frédéric Naudet; Nabila Kadiri; Christian E Gross; Bernard Bioulac; Abdelhamid Benazzouz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

3.  Silent plateau potentials, rhythmic bursts, and pacemaker firing: three patterns of activity that coexist in quadristable subthalamic neurons.

Authors:  Jason I Kass; Isabelle M Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

Review 4.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

5.  Dopaminergic and cholinergic modulation of striatal tyrosine hydroxylase interneurons.

Authors:  Osvaldo Ibáñez-Sandoval; Harry S Xenias; James M Tepper; Tibor Koós
Journal:  Neuropharmacology       Date:  2015-04-20       Impact factor: 5.250

Review 6.  Pathophysiology of parkinsonism.

Authors:  Adriana Galvan; Thomas Wichmann
Journal:  Clin Neurophysiol       Date:  2008-05-07       Impact factor: 3.708

7.  Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys.

Authors:  Michele A Kliem; Jean-Francois Pare; Zafar U Khan; Thomas Wichmann; Yoland Smith
Journal:  Adv Behav Biol       Date:  2009-08-21

8.  A calcium-activated nonselective cation conductance underlies the plateau potential in rat substantia nigra GABAergic neurons.

Authors:  Christian R Lee; James M Tepper
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

9.  Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers.

Authors:  Christopher H So; Vaneeta Verma; Mohammad Alijaniaram; Regina Cheng; Asim J Rashid; Brian F O'Dowd; Susan R George
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

10.  Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.

Authors:  S Akerman; D J Williamson; P J Goadsby
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.